Jü Zhu

545 total citations
34 papers, 435 citations indexed

About

Jü Zhu is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jü Zhu has authored 34 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Jü Zhu's work include Cell death mechanisms and regulation (5 papers), Synthesis and biological activity (4 papers) and Cancer therapeutics and mechanisms (4 papers). Jü Zhu is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Synthesis and biological activity (4 papers) and Cancer therapeutics and mechanisms (4 papers). Jü Zhu collaborates with scholars based in China and United States. Jü Zhu's co-authors include Youjun Zhou, Canhui Zheng, Tingjian Zhang, Shuai Li, Yunlong Song, Xinyang Li, Fan‐hao Meng, Chongqing Wang, Haitao Ji and Tai Shun Lin and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and European Journal of Medicinal Chemistry.

In The Last Decade

Jü Zhu

34 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jü Zhu China 15 250 170 100 74 43 34 435
Naval Kapuriya India 15 274 1.1× 346 2.0× 119 1.2× 35 0.5× 36 0.8× 40 635
L. Pang Belgium 12 411 1.6× 318 1.9× 70 0.7× 62 0.8× 34 0.8× 22 685
Antonio Lupia Italy 14 279 1.1× 87 0.5× 70 0.7× 30 0.4× 56 1.3× 30 523
Siddharth Manvati India 12 326 1.3× 98 0.6× 44 0.4× 31 0.4× 43 1.0× 15 583
Tomomi Noguchi‐Yachide Japan 17 332 1.3× 208 1.2× 109 1.1× 19 0.3× 50 1.2× 36 631
Elisa Robles‐Escajeda United States 12 210 0.8× 173 1.0× 117 1.2× 23 0.3× 15 0.3× 17 466
Rahul Pawara India 17 360 1.4× 372 2.2× 145 1.4× 78 1.1× 45 1.0× 23 726
Dana M. Zaher United Arab Emirates 17 250 1.0× 146 0.9× 121 1.2× 19 0.3× 44 1.0× 30 591
Zhuang Hou China 17 339 1.4× 412 2.4× 47 0.5× 76 1.0× 95 2.2× 39 708
Yahui Huang China 14 441 1.8× 230 1.4× 124 1.2× 66 0.9× 49 1.1× 29 667

Countries citing papers authored by Jü Zhu

Since Specialization
Citations

This map shows the geographic impact of Jü Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jü Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jü Zhu more than expected).

Fields of papers citing papers by Jü Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jü Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jü Zhu. The network helps show where Jü Zhu may publish in the future.

Co-authorship network of co-authors of Jü Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Jü Zhu. A scholar is included among the top collaborators of Jü Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jü Zhu. Jü Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jianhui, et al.. (2023). Discovery of novel 2,3,4,5-tetrahydrospiro[benzo[c]azepine-1,1’-cyclohexan]-5-ol derivatives as PARP-1 inhibitors. BMC Chemistry. 17(1). 147–147. 3 indexed citations
3.
Huang, Wei, et al.. (2021). ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway. OncoTargets and Therapy. Volume 14. 3583–3596. 15 indexed citations
4.
Hu, Chao, Meiying Shen, Xiaojian Han, et al.. (2021). Identification of cross-reactive CD8+ T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants. Genes & Diseases. 9(1). 216–229. 26 indexed citations
5.
6.
Li, Shuai, Xinyang Li, Tingjian Zhang, et al.. (2019). Design, synthesis and biological evaluation of homoerythrina alkaloid derivatives bearing a triazole moiety as PARP-1 inhibitors and as potential antitumor drugs. Bioorganic Chemistry. 94. 103385–103385. 26 indexed citations
7.
Zhang, Minmin, Jian Hu, Chongqing Wang, et al.. (2018). Design, synthesis, and bioactivity evaluation of novel Bcl-2/HDAC dual-target inhibitors for the treatment of multiple myeloma. Bioorganic & Medicinal Chemistry Letters. 29(3). 349–352. 20 indexed citations
8.
Han, Jinsong, Ying Chen, Chao Yang, et al.. (2016). Structure-based optimization leads to the discovery of NSC765844, a highly potent, less toxic and orally efficacious dual PI3K/mTOR inhibitor. European Journal of Medicinal Chemistry. 122. 684–701. 17 indexed citations
9.
Tian, Wei, Chongqing Wang, Chao Yang, et al.. (2016). Design, synthesis, and activity evaluation of selective inhibitors of anti-apoptotic Bcl-2 proteins: The effects on the selectivity of the P1 pockets in the active sites. Bioorganic & Medicinal Chemistry Letters. 26(21). 5207–5211. 6 indexed citations
10.
Zheng, Canhui, Meng Zhang, Hui Chen, et al.. (2014). Luteolin from Flos Chrysanthemi and its derivatives: New small molecule Bcl-2 protein inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(19). 4672–4677. 15 indexed citations
11.
Tian, Wei, Jü Zhu, Qianqian Chen, et al.. (2013). Synthesis and acrosin inhibitory activities of 5-phenyl-1H-pyrazole-3-carboxylic acid amide derivatives. Bioorganic & Medicinal Chemistry Letters. 23(14). 4177–4184. 9 indexed citations
12.
Zhao, Juntao, et al.. (2012). Ethyl 5-(4-aminophenyl)isoxazole-3-carboxylate. Acta Crystallographica Section E Structure Reports Online. 68(4). o1111–o1111. 3 indexed citations
13.
Zheng, Canhui, Jia Liu, Na Liu, et al.. (2012). Synthesis and Biological Evaluation of 1‐Phenyl‐1,2,3,4‐dihydroisoquinoline Compounds as Tubulin Polymerization Inhibitors. Archiv der Pharmazie. 345(6). 454–462. 13 indexed citations
14.
Liu, Xuefei, Guoqiang Dong, Jue Zhang, et al.. (2011). Discovery of novel human acrosin inhibitors by virtual screening. Journal of Computer-Aided Molecular Design. 25(10). 977–985. 9 indexed citations
15.
Zhu, Jü, et al.. (2011). Synthesis and acrosin inhibitory activities of substituted ethyl 5-(4-aminophenyl)-1H-pyrazole-3-carboxylate derivatives. Bioorganic & Medicinal Chemistry Letters. 21(19). 5822–5825. 8 indexed citations
17.
Zhu, Jü, et al.. (2007). Construction of a three-dimensional pharmacophore for Bcl-2 inhibitors by flexible docking and the multiple copy simultaneous search method. Bioorganic & Medicinal Chemistry. 15(19). 6407–6417. 20 indexed citations
18.
Yao, Bin, Youjun Zhou, Jü Zhu, et al.. (2006). Design, Synthesis and Biological Evaluation of Non-azole Inhibitors of Lanosterol 14α-Demethylase of Fungi. Chinese Chemical Letters. 17(9). 1189–1192. 1 indexed citations
19.
Sheng, Chunquan, Wannian Zhang, Min Zhang, et al.. (2004). Homology Modeling of Lanosterol 14α-Demethylase ofCandida albicansandAspergillus fumigatusand Insights into the Enzyme-Substrate Interactions. Journal of Biomolecular Structure and Dynamics. 22(1). 91–99. 57 indexed citations
20.
Rui, Yao‐Cheng, et al.. (1992). Specific binding sites of platelet activating factor on the intact bovine cerebral microvascular endothelial cells and antagonism of drugs.. PubMed. 13(4). 326–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026